Avise Analytics is the fastest growing equity research firm that authors institutional quality equity research reports, with special focus on Nano-Cap and Micro-Cap companies that are undervalued and lacks adequate coverage.
Our team of highly experienced analysts provides a wide range of tailored services in the field of equity, investment and financial research and investor relations to our diversified client base around the world.
Our free mobile app gives you real-time notifications on publication of short company stories for compelling investment ideas so that you never miss an opportunity!
As a step to effectively handle your research team’s workload as a business partner, our free mobile (and tablet friendly) application, also offer you a complete accessibility in tracking your project progress and billing and payment status at the tip of your finger any time.
Download the app for free now to explore our talent pool and feel the difference in outsourcing your work to us.
We pride ourselves in constantly delivering high-quality and scalable equity, investment and credit research solutions to our diversified client base across 9 countries. A snapshot of our key experience in past 3 years includes:
The Global legal marijuana market is likely to reach over USD 66.3 billion by the end of 2025, as per a report by Grand ...17 February, 2020No comment
Cannabics Pharmaceuticals (OTCQB: CNBX), an early-stage Biotechnology Company focussed on creating cannabinoid-based the...14 February, 2020No comment
Aurora Mobile (NASDAQ: JG), a leading developer of big data mobile solutions, announced the launch of a suite of proprie...13 February, 2020No comment
INmune Bio (NASDAQ: INMB), a clinical-stage Company focussed on creating novel immunotherapies for the treatment of hema...12 February, 2020No comment
SeaSpine Holdings Corporation (NASDAQ: SPNE), a Company leveraging technology to develop surgical solutions for spinal d...10 February, 2020No comment
Cure Pharmaceutical (OTCQB: CURR), a Company leveraging its proprietary drug dosage forms and delivery systems to create...07 February, 2020No comment
TransAct Technologies Inc (NASDAQ: TACT), a Company developing innovative printing solutions and software-driven technol...06 February, 2020No comment
Co-Diagnostics (NASDAQ: CODX), a molecular Diagnostics Company focused on developing nucleic acid molecule based reagent...05 February, 2020No comment
OptimizeRx Corporation (NASDAQ: OPRX), a pioneer in the cloud-based digital health messaging solutions arena that create...04 February, 2020No comment
According to the World Health Organization (WHO), Coronovirus (CoV) is a family of viruses that cause illnesses ranging ...03 February, 2020No comment
iAnthus Capital Holdings (OTCQX: ITHUF), a multistate cannabis operator with cultivation, processing and over 30 dispens...31 January, 2020No comment
ReposiTrak (Park City Group (NASDAQ: PCYG)), an out-of-specification (OOS) Management Solution which addresses one of th...30 January, 2020No comment
Concert Pharmaceuticals (NASDAQ: CNCE), a clinical stage biopharmaceutical Company, announced the receipt of a Notice of...29 January, 2020No comment
Inovio Pharmaceuticals (NASDAQ: INO), a late-stage biotechnology Company developing DNA-based immunotherapies and vaccin...28 January, 2020No comment
Melinta Therapeutics (NASDAQ: MLNT), a commercial-stage pharmaceutical Company, engaged in developing therapeutic option...27 January, 2020No comment
Avise Analytics is a professionally managed organization and understood job scopes & requirements very well. The report and analysis generated meet my expectations and will not hesitate to recommend others.
Delivered a high-quality set of documents that exceeded my expectations. Keep up the good work!!
Great team. We ramped up our coverage universe quickly due to their help. I highly recommend them!
High quality equity research provider that we now use for regular work
Excellent communication skills and a high commitment to client satisfaction.
Instrumental in helping us complete the research in such a tight timeline!
I have found Avise Analytics to be a great, cost-effective solution to providing both simple and complex finance-related articles for various blogs and newsletters. They are detailed oriented, consciences, respond well to direction, prompt and really know the finance industry.